Free Trial
→ July 2025 Rule Change to Impact Retirement Investors (From Premier Gold Co) (Ad) Buy SNPS Stock  Free SNPS Stock Alerts

Synopsys (SNPS) Financials

Synopsys logo
$462.43 -49.36 (-9.64%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$472.50 +10.07 (+2.18%)
As of 08:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Synopsys

Annual Income Statements for Synopsys

This table shows Synopsys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 10/31/2024 10/31/2023 10/31/2022 10/31/2021 10/31/2020 10/31/2019 10/31/2018 10/31/2017 10/31/2016 10/31/2015
Net Income / (Loss) Attributable to Common Shareholders		 2,263 1,230 985 758 664 532 433 137 267 226
Consolidated Net Income / (Loss)		 2,236 1,218 978 756 663 532 433 137 267 226
Net Income / (Loss) Continuing Operations		 1,414 1,215 964 756 663 532 433 137 267 226
Total Pre-Tax Income 		1,514 1,305 1,103 806 638 546 364 383 330 282
Total Operating Income		 1,356 1,273 1,149 735 620 520 360 348 317 266
Total Gross Profit		 4,882 4,287 3,718 3,342 2,891 2,608 2,385 2,071 1,880 1,723
Total Revenue		 6,127 5,318 4,616 4,204 3,685 3,361 3,121 2,725 2,423 2,242
Operating Revenue		 6,127 5,318 4,616 4,204 3,685 3,361 3,121 2,725 2,423 2,242
Total Cost of Revenue		 1,245 1,031 898 862 795 753 736 654 543 519
Operating Cost of Revenue		 1,245 1,031 898 862 795 753 736 654 543 519
Total Operating Expenses		 3,526 3,014 2,569 2,608 2,270 2,088 2,025 1,723 1,562 1,457
Selling, General & Admin Expense		 568 377 314 323 285 229 263 197 166 165
Marketing Expense		 859 725 643 712 632 633 623 549 502 474
Research & Development Expense		 2,082 1,850 1,590 1,505 1,279 1,137 1,085 909 857 776
Amortization Expense		 16 9.30 12 - - - 42 - - -
Restructuring Charge		 0.00 53 11 33 36 47 13 37 9.63 15
Total Other Income / (Expense), net		 158 32 -45 71 18 25 3.32 36 12 15
Other Income / (Expense), net		 158 32 -45 71 18 25 3.32 36 12 15
Income Tax Expense		 100 90 139 49 -25 13 -69 247 63 56
Net Income / (Loss) Discontinued Operations		 822 2.84 14 - - - - - - -
Net Income / (Loss) Attributable to Noncontrolling Interest		 -28 -12 -6.16 -1.16 -0.90 0.00 0.00 - - -
Basic Earnings per Share		 $14.78 $8.08 $6.44 $4.96 $4.40 $3.55 $2.90 $0.91 $1.76 $1.46
Weighted Average Basic Shares Outstanding		 153.14M 152.15M 153.00M 152.70M 151.14M 149.87M 149.04M 150.46M 152.02M 154.96M
Diluted Earnings per Share		 $14.51 $7.92 $6.29 $4.81 $4.27 $3.45 $2.82 $0.88 $1.73 $1.43
Weighted Average Diluted Shares Outstanding		 155.94M 155.20M 156.49M 157.34M 155.71M 154.19M 153.39M 154.87M 154.72M 158.07M
Weighted Average Basic & Diluted Shares Outstanding		 154.58M 151.99M 152.42M 153.44M 153.03M 150.53M 149.52M 148.71M 151.60M 154.70M

Quarterly Income Statements for Synopsys

This table shows Synopsys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Income / (Loss) Attributable to Common Shareholders		 296 1,114 408 292 449 349 336 273 272 154 223
Consolidated Net Income / (Loss)		 297 1,096 405 289 446 346 333 270 269 152 220
Net Income / (Loss) Continuing Operations		 297 249 423 296 435 5.80 668 273 269 137 220
Total Pre-Tax Income 		291 315 392 342 457 404 326 297 279 200 236
Total Operating Income		 252 304 360 332 353 425 300 292 256 204 234
Total Gross Profit		 1,185 1,173 1,235 1,154 1,232 1,102 1,094 1,015 1,077 701 977
Total Revenue		 1,455 1,498 1,526 1,455 1,511 1,340 1,354 1,263 1,361 818 1,248
Operating Revenue		 1,455 1,498 1,526 1,455 1,511 1,340 1,354 1,263 1,361 818 1,248
Total Cost of Revenue		 270 325 291 300 279 238 260 248 284 117 271
Operating Cost of Revenue		 270 325 291 300 279 238 260 248 284 117 271
Total Operating Expenses		 934 869 875 822 879 677 794 722 821 497 743
Selling, General & Admin Expense		 167 165 150 115 131 95 100 85 97 67 91
Marketing Expense		 209 175 211 210 219 148 186 181 211 71 199
Research & Development Expense		 553 528 509 493 526 440 484 460 465 371 445
Amortization Expense		 4.00 - - - 3.53 - 2.01 - - - -
Total Other Income / (Expense), net		 39 11 32 9.46 105 -21 25 4.21 23 -3.98 2.43
Other Income / (Expense), net		 39 11 32 9.46 105 -21 25 4.21 23 -3.98 2.43
Income Tax Expense		 -6.29 66 -31 45 23 63 -6.95 24 11 63 17
Net Income / (Loss) Discontinued Operations		 0.00 - -18 -7.00 12 - 1.09 -2.69 - - -
Net Income / (Loss) Attributable to Noncontrolling Interest		 1.73 -18 -3.16 -3.02 -2.91 -2.70 -3.20 -2.96 -2.91 -1.94 -2.98
Basic Earnings per Share		 $1.91 $7.26 $2.66 $1.91 $2.95 $2.30 $2.21 $1.79 $1.78 $1.00 $1.46
Weighted Average Basic Shares Outstanding		 154.41M 153.14M 153.42M 152.97M 152.31M 152.15M 152.02M 152.19M 152.40M 153.00M 152.94M
Diluted Earnings per Share		 $1.89 $7.13 $2.61 $1.88 $2.89 $2.24 $2.17 $1.76 $1.75 $0.98 $1.43
Weighted Average Diluted Shares Outstanding		 156.19M 155.94M 156.13M 155.77M 155.33M 155.20M 154.95M 154.73M 155.08M 156.49M 155.81M
Weighted Average Basic & Diluted Shares Outstanding		 154.62M 154.58M 153.61M 153.22M 152.54M 151.99M 304.17M 304.32M 152.30M 152.42M 152.91M

Annual Cash Flow Statements for Synopsys

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 10/31/2024 10/31/2023 10/31/2022 10/31/2021 10/31/2020 10/31/2019 10/31/2018 10/31/2017 10/31/2016 10/31/2015
Net Change in Cash & Equivalents		 2,458 21 -15 197 507 2.74 -325 70 140 -150
Net Cash From Operating Activities		 1,407 1,703 1,739 1,493 991 801 424 632 587 495
Net Cash From Continuing Operating Activities		 1,407 1,703 1,739 1,493 991 801 424 632 587 495
Net Income / (Loss) Continuing Operations		 2,236 1,218 978 756 663 532 433 137 267 226
Consolidated Net Income / (Loss)		 2,236 1,218 978 756 663 532 433 137 267 226
Depreciation Expense		 295 247 228 204 210 202 209 189 207 212
Amortization Expense		 107 82 73 65 61 63 0.00 0.00 - -
Non-Cash Adjustments To Reconcile Net Income		 -116 694 555 466 357 162 142 112 99 88
Changes in Operating Assets and Liabilities, net		 -1,115 -538 -96 1.60 -300 -158 -360 195 14 -30
Net Cash From Investing Activities		 1,223 -482 -573 -549 -360 -236 -744 -189 -143 -560
Net Cash From Continuing Investing Activities		 1,223 -482 -573 -549 -360 -236 -744 -189 -143 -560
Purchase of Property, Plant & Equipment		 -123 -192 -139 -96 -159 -202 -102 -74 -71 -91
Acquisitions		 -157 -298 -422 -296 -201 -37 -653 -259 -60 -340
Purchase of Investments		 -138 -132 -104 -169 -2.76 -3.25 -3.56 -155 -170 -239
Divestitures		 1,447 0.00 0.00 - - - - - - -
Sale and/or Maturity of Investments		 195 139 94 13 2.15 6.36 13 296 158 109
Other Investing Activities, net		 0.00 0.00 -1.20 -0.80 0.00 0.00 - 2.10 0.00 0.90
Net Cash From Financing Activities		 -181 -1,197 -1,116 -749 -141 -562 5.14 -373 -307 -62
Net Cash From Continuing Financing Activities		 -181 -1,197 -1,116 -749 -141 -562 5.14 -373 -307 -62
Repayment of Debt		 -76 -2.73 -80 -32 -290 -525 -294 -383 -191 -327
Repurchase of Common Equity		 0.00 -1,206 -1,100 -788 -242 -329 -400 -400 -400 -280
Issuance of Common Equity		 232 253 238 211 197 156 124 126 125 110
Other Financing Activities, net		 -338 -241 -174 -139 -82 -57 -46 -37 -27 -25
Effect of Exchange Rate Changes		 8.80 -2.98 -65 2.37 17 - -11 - 3.41 -23
Cash Interest Paid		 0.81 1.00 1.26 3.37 5.14 12 15 7.10 3.71 2.71
Cash Income Taxes Paid		 680 98 168 150 71 76 253 103 69 60

Quarterly Cash Flow Statements for Synopsys

This table details how cash moves in and out of Synopsys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Change in Cash & Equivalents		 -241 2,039 348 390 -320 -247 142 389 -263 34 -190
Net Cash From Operating Activities		 -67 563 455 477 -88 326 560 703 115 394 440
Net Cash From Continuing Operating Activities		 -67 563 455 477 -88 326 560 703 115 394 440
Net Income / (Loss) Continuing Operations		 297 1,096 405 289 446 346 333 270 269 152 220
Consolidated Net Income / (Loss)		 297 1,096 405 289 446 346 333 270 269 152 220
Depreciation Expense		 48 115 56 61 63 67 63 60 57 59 58
Amortization Expense		 23 32 31 25 20 21 22 21 19 19 20
Non-Cash Adjustments To Reconcile Net Income		 222 -684 209 204 155 179 179 170 166 150 154
Changes in Operating Assets and Liabilities, net		 -658 4.52 -245 -103 -772 -287 -37 182 -396 15 -12
Net Cash From Investing Activities		 -22 1,443 -54 -112 -54 -301 -54 -91 -36 -41 -345
Net Cash From Continuing Investing Activities		 -22 1,443 -54 -112 -54 -301 -54 -91 -36 -41 -345
Purchase of Property, Plant & Equipment		 -41 -4.39 -40 -38 -40 -53 -46 -48 -44 -36 -36
Acquisitions		 0.00 - -17 -72 -68 -246 -10 -41 0.00 -6.05 -307
Purchase of Investments		 -41 -40 -32 -40 -26 -29 -34 -40 -29 -24 -28
Divestitures		 24 - - - 0.00 - - - - - -
Sale and/or Maturity of Investments		 36 40 35 39 80 28 36 38 37 23 27
Other Investing Activities, net		 -0.61 - - - 0.00 - - - - 1.97 -1.51
Net Cash From Financing Activities		 -142 30 -57 33 -187 -254 -351 -214 -377 -291 -266
Net Cash From Continuing Financing Activities		 -142 30 -57 33 -187 -254 -351 -214 -377 -291 -266
Repayment of Debt		 -1.29 - -19 -7.81 -49 - -1.31 -0.12 -1.29 - -1.60
Payment of Dividends		 -30 - - - 0.00 - - - - - -
Issuance of Common Equity		 14 89 28 106 9.48 88 32 110 22 77 41
Other Financing Activities, net		 -125 -59 -66 -65 -147 -42 -82 -25 -92 -25 -48
Effect of Exchange Rate Changes		 -9.68 3.34 3.04 -6.90 9.32 -18 -13 -7.97 36 -27 -18

Annual Balance Sheets for Synopsys

This table presents Synopsys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 10/31/2024 10/31/2023 10/31/2022 10/31/2021 10/31/2020 10/31/2019 10/31/2018 10/31/2017 10/31/2016 10/31/2015
Total Assets		 13,074 10,333 9,418 8,752 8,030 6,405 6,146 5,396 5,240 5,046
Total Current Assets		 6,470 3,431 3,013 2,808 2,549 1,739 1,544 1,683 1,717 1,469
Cash & Equivalents		 3,897 1,434 1,418 1,433 1,236 729 723 1,048 977 836
Short-Term Investments		 154 152 148 148 0.00 - - - 141 129
Accounts Receivable		 934 857 796 569 781 554 554 451 439 386
Inventories, net		 362 326 212 229 192 142 122 62 - -
Prepaid Expenses		 1,123 548 439 430 308 290 68 73 105 71
Plant, Property, & Equipment, net		 563 550 483 472 484 430 309 266 257 263
Total Noncurrent Assets		 6,041 6,353 5,922 5,472 4,997 4,237 4,293 3,448 3,266 3,314
Goodwill		 3,449 3,346 3,842 3,576 3,365 3,171 3,143 2,707 2,518 2,471
Intangible Assets		 195 240 386 279 254 279 360 254 267 364
Noncurrent Deferred & Refundable Income Taxes		 1,247 854 671 613 498 390 404 244 282 274
Other Noncurrent Operating Assets		 1,150 1,005 1,023 1,004 880 396 385 243 200 205
Total Liabilities & Shareholders' Equity		 13,074 10,333 9,418 8,752 8,030 6,405 6,146 5,396 5,240 5,046
Total Liabilities		 4,050 4,149 3,859 3,453 3,118 2,316 2,661 2,117 2,045 1,912
Total Current Liabilities		 2,650 2,985 2,774 2,413 2,140 1,752 2,102 1,614 1,715 1,578
Accounts Payable		 1,164 1,060 809 741 624 506 578 500 401 386
Current Deferred Revenue		 1,392 1,559 1,911 1,518 1,388 1,212 1,153 1,065 1,086 968
Other Current Liabilities		 95 80 54 80 73 0.00 - - - -
Total Noncurrent Liabilities		 1,400 1,163 1,084 1,040 978 564 559 503 330 333
Long-Term Debt		 16 18 21 25 101 120 126 134 0.00 -
Noncurrent Deferred Revenue		 341 151 154 136 130 120 167 116 119 131
Other Noncurrent Operating Liabilities		 1,044 961 909 878 747 324 266 252 211 202
Redeemable Noncontrolling Interest		 30 31 39 0.00 - - - - - -
Total Equity & Noncontrolling Interests		 8,993 6,153 5,521 5,299 4,912 4,089 3,485 3,280 3,195 3,134
Total Preferred & Common Equity		 8,991 6,147 5,516 5,295 4,907 4,083 3,479 3,276 3,195 3,134
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 8,991 6,147 5,516 5,295 4,907 4,083 3,479 3,276 3,195 3,134
Common Stock		 1,213 1,278 1,489 1,578 1,655 1,637 1,646 1,624 1,646 1,612
Retained Earnings		 8,984 6,742 5,534 4,550 3,795 3,164 2,544 2,144 1,948 1,726
Treasury Stock		 -1,026 -1,676 -1,273 -783 -489 -626 -598 -426 -294 -98
Accumulated Other Comprehensive Income / (Loss)		 -180 -196 -234 -50 -54 -92 -113 -66 -105 -105
Noncontrolling Interest		 2.50 5.95 4.80 3.81 4.96 5.86 5.86 4.10 0.00 -

Quarterly Balance Sheets for Synopsys

This table presents Synopsys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Total Assets		 13,041 13,074 11,649 11,012 10,558 10,333 9,923 9,791 9,566 9,418 9,330
Total Current Assets		 6,324 6,470 5,128 4,653 3,408 3,431 3,268 3,161 3,028 3,013 2,899
Cash & Equivalents		 3,654 3,897 1,840 1,503 1,119 1,434 1,686 1,545 1,155 1,418 1,384
Short-Term Investments		 155 154 154 157 154 152 148 151 147 148 148
Accounts Receivable		 893 934 805 835 1,064 857 667 780 1,035 796 683
Inventories, net		 415 362 386 378 383 326 283 256 221 212 220
Prepaid Expenses		 1,206 1,123 915 760 688 548 484 429 470 439 465
Plant, Property, & Equipment, net		 546 563 571 567 567 550 536 546 517 483 487
Total Noncurrent Assets		 6,171 6,041 5,950 5,792 6,583 6,353 6,119 6,083 6,020 5,922 5,944
Goodwill		 3,433 3,449 3,444 3,427 4,131 3,346 3,888 3,888 3,865 3,842 3,855
Intangible Assets		 181 195 266 277 377 240 337 357 361 386 405
Noncurrent Deferred & Refundable Income Taxes		 1,393 1,247 1,103 1,005 954 854 814 774 719 671 617
Other Noncurrent Operating Assets		 1,164 1,150 1,136 1,083 1,120 1,005 1,081 1,064 1,075 1,023 1,067
Total Liabilities & Shareholders' Equity		 13,041 13,074 11,649 11,012 10,558 10,333 9,923 9,791 9,566 9,418 9,330
Total Liabilities		 3,736 4,050 3,903 3,823 3,852 4,149 3,923 3,918 3,887 3,859 3,678
Total Current Liabilities		 2,359 2,650 2,535 2,508 2,645 2,985 2,730 2,749 2,725 2,774 2,546
Accounts Payable		 939 1,164 757 636 699 1,060 905 702 664 809 736
Current Deferred Revenue		 1,321 1,392 1,357 1,457 1,856 1,559 1,744 1,969 1,995 1,911 1,756
Other Current Liabilities		 99 95 90 85 89 80 80 78 66 54 54
Total Noncurrent Liabilities		 1,378 1,400 1,368 1,315 1,207 1,163 1,193 1,169 1,162 1,084 1,132
Long-Term Debt		 14 16 16 17 17 18 18 20 21 21 22
Noncurrent Deferred Revenue		 316 341 319 308 190 151 195 191 173 154 165
Other Noncurrent Operating Liabilities		 1,047 1,044 1,034 990 1,000 961 980 958 969 909 945
Redeemable Noncontrolling Interest		 0.00 30 31 31 31 31 36 36 36 39 44
Total Equity & Noncontrolling Interests		 9,305 8,993 7,714 7,158 6,676 6,153 5,964 5,837 5,643 5,521 5,608
Total Preferred & Common Equity		 9,305 8,991 7,709 7,153 6,671 6,147 5,959 5,832 5,637 5,516 5,604
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 9,305 8,991 7,709 7,153 6,671 6,147 5,959 5,832 5,637 5,516 5,604
Common Stock		 1,129 1,213 1,194 1,184 1,185 1,278 1,259 1,332 1,294 1,489 1,417
Retained Earnings		 9,279 8,984 7,884 7,478 7,189 6,742 6,390 6,075 5,806 5,534 5,378
Treasury Stock		 -861 -1,026 -1,188 -1,322 -1,539 -1,676 -1,543 -1,429 -1,321 -1,273 -1,035
Accumulated Other Comprehensive Income / (Loss)		 -242 -180 -180 -188 -163 -196 -147 -146 -142 -234 -155
Noncontrolling Interest		 0.11 2.50 4.98 4.64 4.59 5.95 5.45 5.09 5.95 4.80 4.10

Annual Metrics And Ratios for Synopsys

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 10/31/2024 10/31/2023 10/31/2022 10/31/2021 10/31/2020 10/31/2019 10/31/2018 10/31/2017 10/31/2016 10/31/2015
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 15.22% 15.22% 9.79% 14.08% 9.66% 7.68% 14.54% 12.48% 8.04% 8.98%
EBITDA Growth		 17.21% 16.36% 30.82% 18.10% 12.27% 41.41% 0.04% 6.70% 8.74% 6.12%
EBIT Growth		 15.96% 18.31% 36.99% 26.22% 16.98% 50.05% -5.10% 16.25% 17.02% 3.48%
NOPAT Growth		 6.85% 18.10% 45.46% 7.02% 26.99% 18.46% 245.91% -51.79% 20.21% -9.73%
Net Income Growth		 83.55% 24.50% 29.36% 14.00% 24.62% 23.09% 216.72% -48.82% 18.10% -12.81%
EPS Growth		 83.21% 25.91% 30.77% 12.65% 23.77% 22.34% 220.45% -49.13% 20.98% -12.80%
Operating Cash Flow Growth		 -17.39% -2.05% 16.50% 50.57% 23.83% 88.62% -32.90% 7.82% 18.47% -10.13%
Free Cash Flow Firm Growth		 -85.17% 59.40% 19.37% 100.05% 40.33% 156.38% -1,461.98% -90.99% 2,442.96% 60.63%
Invested Capital Growth		 27.49% -2.53% 5.14% 0.36% 8.77% 8.26% 36.03% 4.05% -3.84% 10.66%
Revenue Q/Q Growth		 -5.64% 1.05% -6.75% 3.11% 4.97% 1.69% 3.26% 2.36% 1.96% 2.19%
EBITDA Q/Q Growth		 -1.34% 14.12% 0.58% 0.99% 7.20% 11.95% -5.61% 2.38% 3.62% -0.20%
EBIT Q/Q Growth		 -5.33% 17.24% 0.09% 0.94% 10.37% 17.03% -11.59% 4.69% 8.86% -2.16%
NOPAT Q/Q Growth		 -8.90% 20.78% -5.17% -1.12% 7.27% -16.37% 676.85% -59.35% 9.16% -3.21%
Net Income Q/Q Growth		 50.39% 19.05% -4.82% 0.61% 5.71% -14.95% 644.33% -58.53% 9.40% -5.32%
EPS Q/Q Growth		 50.83% 18.92% -4.41% 0.00% 6.22% -15.44% 605.00% -58.49% 9.49% -4.67%
Operating Cash Flow Q/Q Growth		 20.23% -3.81% 1.34% 12.72% -1.89% 12.72% -10.89% 5.88% -0.80% -3.97%
Free Cash Flow Firm Q/Q Growth		 -62.08% 36.85% 24.58% 4.33% 7.98% -6.09% 1.24% -44.60% 124.86% -108.82%
Invested Capital Q/Q Growth		 -1.62% -6.47% -3.09% 2.31% 3.31% 3.04% 6.14% -7.09% -1.11% 6.56%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 79.68% 80.62% 80.54% 79.50% 78.44% 77.60% 76.42% 75.99% 77.59% 76.86%
EBITDA Margin		 31.27% 30.74% 30.44% 25.54% 24.67% 24.10% 18.35% 21.01% 22.15% 22.01%
Operating Margin		 22.13% 23.94% 24.89% 17.48% 16.83% 15.48% 11.54% 12.76% 13.10% 11.88%
EBIT Margin		 24.71% 24.55% 23.91% 19.16% 17.32% 16.23% 11.65% 14.06% 13.60% 12.56%
Profit (Net Income) Margin		 36.49% 22.91% 21.20% 17.99% 18.00% 15.84% 13.86% 5.01% 11.01% 10.08%
Tax Burden Percent		 147.69% 93.31% 88.67% 93.90% 103.96% 97.59% 118.97% 35.65% 80.97% 80.23%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 6.59% 6.91% 12.63% 6.10% -3.96% 2.41% -18.97% 64.35% 19.03% 19.77%
Return on Invested Capital (ROIC)		 28.45% 29.90% 25.63% 18.10% 17.66% 15.09% 15.29% 5.32% 11.04% 9.46%
ROIC Less NNEP Spread (ROIC-NNEP)		 -2.29% 28.18% 27.29% 12.97% 15.45% 9.25% 14.61% 3.93% 9.86% 8.01%
Return on Net Nonoperating Assets (RNNOA)		 0.95% -9.16% -7.60% -3.29% -2.92% -1.03% -2.50% -1.10% -2.61% -2.16%
Return on Equity (ROE)		 29.40% 20.75% 18.02% 14.81% 14.74% 14.06% 12.79% 4.22% 8.43% 7.30%
Cash Return on Invested Capital (CROIC)		 4.29% 32.47% 20.62% 17.74% 9.26% 7.16% -15.24% 1.35% 14.95% -0.66%
Operating Return on Assets (OROA)		 12.94% 13.22% 12.15% 9.60% 8.84% 8.69% 6.30% 7.20% 6.41% 5.73%
Return on Assets (ROA)		 19.10% 12.33% 10.77% 9.01% 9.19% 8.48% 7.49% 2.57% 5.19% 4.60%
Return on Common Equity (ROCE)		 29.27% 20.60% 17.94% 14.80% 14.72% 14.04% 12.77% 4.22% 8.43% 7.30%
Return on Equity Simple (ROE_SIMPLE)		 24.87% 19.82% 17.74% 14.28% 13.52% 13.04% 12.43% 4.17% 8.35% 7.21%
Net Operating Profit after Tax (NOPAT)		 1,266 1,185 1,004 690 645 508 429 124 257 214
NOPAT Margin		 20.67% 22.29% 21.74% 16.41% 17.49% 15.11% 13.73% 4.55% 10.61% 9.53%
Net Nonoperating Expense Percent (NNEP)		 30.74% 1.72% -1.66% 5.13% 2.21% 5.84% 0.68% 1.39% 1.18% 1.45%
Return On Investment Capital (ROIC_SIMPLE)		 14.06% 19.21% 18.11% - - - - - - -
Cost of Revenue to Revenue		 20.32% 19.38% 19.46% 20.50% 21.56% 22.40% 23.58% 24.01% 22.41% 23.14%
SG&A Expenses to Revenue		 9.28% 7.08% 6.79% 7.68% 7.72% 6.82% 8.41% 7.22% 6.85% 7.36%
R&D to Revenue		 33.98% 34.79% 34.44% 35.79% 34.71% 33.83% 34.76% 33.35% 35.36% 34.62%
Operating Expenses to Revenue		 57.55% 56.67% 55.66% 62.02% 61.61% 62.12% 64.88% 63.24% 64.49% 64.97%
Earnings before Interest and Taxes (EBIT)		 1,514 1,305 1,103 806 638 546 364 383 330 282
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1,916 1,635 1,405 1,074 909 810 573 573 537 493
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 8.78 11.61 8.11 9.60 6.61 5.00 3.82 3.97 2.81 2.49
Price to Tangible Book Value (P/TBV)		 14.76 27.87 34.76 35.28 25.20 32.26 0.00 41.29 21.88 26.06
Price to Revenue (P/Rev)		 12.88 13.43 9.69 12.09 8.81 6.07 4.26 4.77 3.71 3.48
Price to Earnings (P/E)		 34.86 58.05 45.43 67.08 48.85 38.32 30.76 95.19 33.64 34.50
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.87% 1.72% 2.20% 1.49% 2.05% 2.61% 3.25% 1.05% 2.97% 2.90%
Enterprise Value to Invested Capital (EV/IC)		 15.01 17.85 10.77 12.92 8.24 5.67 4.04 5.09 3.53 2.96
Enterprise Value to Revenue (EV/Rev)		 12.22 13.14 9.37 11.73 8.51 5.90 4.18 4.44 3.33 3.14
Enterprise Value to EBITDA (EV/EBITDA)		 39.09 42.74 30.77 45.94 34.48 24.47 22.79 21.13 15.03 14.26
Enterprise Value to EBIT (EV/EBIT)		 49.47 53.52 39.18 61.25 49.13 36.33 35.91 31.58 24.47 24.98
Enterprise Value to NOPAT (EV/NOPAT)		 59.14 58.94 43.08 71.50 48.63 39.03 30.46 97.66 31.38 32.90
Enterprise Value to Operating Cash Flow (EV/OCF)		 53.23 41.02 24.86 33.05 31.63 24.75 30.76 19.13 13.75 14.21
Enterprise Value to Free Cash Flow (EV/FCFF)		 392.40 54.29 53.55 72.94 92.74 82.25 0.00 385.67 23.16 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.02 0.03 0.03 0.13 0.04 0.06 0.07
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.02 0.03 0.04 0.04 0.00 0.00
Financial Leverage		 -0.41 -0.33 -0.28 -0.25 -0.19 -0.11 -0.17 -0.28 -0.26 -0.27
Leverage Ratio		 1.54 1.68 1.67 1.64 1.60 1.66 1.71 1.64 1.63 1.59
Compound Leverage Factor		 1.54 1.68 1.67 1.64 1.60 1.66 1.71 1.64 1.63 1.59
Debt to Total Capital		 0.17% 0.29% 0.37% 1.85% 2.54% 3.26% 11.87% 4.21% 6.03% 6.14%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 1.39% 0.54% 0.42% 8.69% 0.29% 6.03% 6.14%
Long-Term Debt to Total Capital		 0.17% 0.29% 0.37% 0.46% 2.00% 2.84% 3.17% 3.92% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.36% 0.60% 0.78% 0.07% 0.10% 0.14% 0.15% 0.12% 0.00% 0.00%
Common Equity to Total Capital		 99.47% 99.11% 98.85% 98.08% 97.36% 96.60% 87.98% 95.67% 93.97% 93.86%
Debt to EBITDA		 0.01 0.01 0.01 0.09 0.14 0.17 0.82 0.25 0.38 0.42
Net Debt to EBITDA		 -2.11 -0.96 -1.10 -1.38 -1.22 -0.73 -0.44 -1.58 -1.70 -1.54
Long-Term Debt to EBITDA		 0.01 0.01 0.01 0.02 0.11 0.15 0.22 0.23 0.00 0.00
Debt to NOPAT		 0.01 0.02 0.02 0.15 0.20 0.27 1.10 1.16 0.80 0.96
Net Debt to NOPAT		 -3.19 -1.32 -1.54 -2.15 -1.72 -1.16 -0.59 -7.30 -3.55 -3.55
Long-Term Debt to NOPAT		 0.01 0.02 0.02 0.04 0.16 0.24 0.29 1.08 0.00 0.00
Altman Z-Score		 13.85 12.22 8.69 10.39 7.69 6.78 4.17 5.00 3.82 3.53
Noncontrolling Interest Sharing Ratio		 0.46% 0.69% 0.44% 0.09% 0.12% 0.15% 0.15% 0.06% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 2.44 1.15 1.09 1.16 1.19 0.99 0.73 1.04 1.00 0.93
Quick Ratio		 1.88 0.82 0.85 0.89 0.94 0.73 0.61 0.93 0.91 0.86
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 191 1,287 807 676 338 241 -427 31 348 -15
Operating Cash Flow to CapEx		 1,142.43% 887.95% 1,250.27% 1,559.04% 624.40% 395.53% 423.28% 859.89% 825.78% 546.25%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.52 0.54 0.51 0.50 0.51 0.54 0.54 0.51 0.47 0.46
Accounts Receivable Turnover		 6.84 6.44 6.77 6.23 5.52 6.07 6.21 6.12 5.88 6.29
Inventory Turnover		 3.62 3.84 4.07 4.09 4.76 5.71 7.99 0.00 0.00 0.00
Fixed Asset Turnover		 11.01 10.29 9.66 8.79 8.07 9.10 10.85 10.42 9.32 8.76
Accounts Payable Turnover		 1.12 1.10 1.16 1.26 1.41 1.39 1.37 1.45 1.38 1.33
Days Sales Outstanding (DSO)		 53.35 56.72 53.95 58.57 66.09 60.18 58.79 59.61 62.12 57.99
Days Inventory Outstanding (DIO)		 100.75 95.16 89.61 89.23 76.67 63.97 45.70 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 325.86 330.94 315.12 289.04 259.53 262.93 267.38 251.44 264.52 275.25
Cash Conversion Cycle (CCC)		 -171.77 -179.06 -171.55 -141.24 -116.77 -138.79 -162.89 -191.83 -202.41 -217.27
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 4,988 3,913 4,014 3,818 3,805 3,498 3,231 2,375 2,283 2,374
Invested Capital Turnover		 1.38 1.34 1.18 1.10 1.01 1.00 1.11 1.17 1.04 0.99
Increase / (Decrease) in Invested Capital		 1,076 -102 196 14 307 267 856 93 -91 229
Enterprise Value (EV)		 74,895 69,864 43,233 49,334 31,353 19,816 13,055 12,099 8,064 7,034
Market Capitalization		 78,898 71,394 44,734 50,811 32,456 20,401 13,303 12,999 8,976 7,794
Book Value per Share		 $58.53 $40.42 $36.07 $34.72 $32.34 $27.17 $23.41 $21.80 $21.11 $20.10
Tangible Book Value per Share		 $34.81 $16.84 $8.42 $9.44 $8.49 $4.21 ($0.16) $2.10 $2.71 $1.92
Total Capital		 9,039 6,202 5,580 5,399 5,040 4,227 3,954 3,424 3,400 3,339
Total Debt		 16 18 21 100 128 138 469 144 205 205
Total Long-Term Debt		 16 18 21 25 101 120 126 134 0.00 0.00
Net Debt		 -4,035 -1,568 -1,545 -1,481 -1,108 -591 -254 -904 -912 -760
Capital Expenditures (CapEx)		 123 192 139 96 159 202 100 74 71 91
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -231 -1,140 -1,327 -1,111 -799 -725 -938 -970 -910 -869
Debt-free Net Working Capital (DFNWC)		 3,820 445 238 470 436 4.08 -215 78 207 95
Net Working Capital (NWC)		 3,820 445 238 395 409 -14 -559 68 1.99 -110
Net Nonoperating Expense (NNE)		 -969 -33 25 -66 -19 -25 -3.95 -13 -9.84 -12
Net Nonoperating Obligations (NNO)		 -4,035 -2,271 -1,545 -1,481 -1,108 -591 -254 -904 -912 -760
Total Depreciation and Amortization (D&A)		 402 329 301 268 271 264 209 189 207 212
Debt-free, Cash-free Net Working Capital to Revenue		 -3.77% -21.44% -28.76% -26.42% -21.69% -21.56% -30.05% -35.60% -37.58% -38.78%
Debt-free Net Working Capital to Revenue		 62.34% 8.37% 5.16% 11.18% 11.84% 0.12% -6.88% 2.88% 8.54% 4.26%
Net Working Capital to Revenue		 62.34% 8.37% 5.16% 9.39% 11.11% -0.40% -17.90% 2.51% 0.08% -4.89%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $14.78 $8.08 $6.44 $4.96 $4.40 $3.55 $2.90 $0.91 $1.76 $1.46
Adjusted Weighted Average Basic Shares Outstanding		 153.14M 152.15M 153.00M 152.70M 151.14M 149.87M 149.04M 150.46M 152.02M 154.96M
Adjusted Diluted Earnings per Share		 $14.51 $7.92 $6.29 $4.81 $4.27 $3.45 $2.82 $0.88 $1.73 $1.43
Adjusted Weighted Average Diluted Shares Outstanding		 155.94M 155.20M 156.49M 157.34M 155.71M 154.19M 153.39M 154.87M 154.72M 158.07M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 154.58M 151.99M 152.42M 153.44M 153.03M 150.53M 149.52M 148.71M 150.10M 151.45M
Normalized Net Operating Profit after Tax (NOPAT)		 1,266 1,235 1,013 721 459 554 261 269 265 226
Normalized NOPAT Margin		 20.67% 23.22% 21.96% 17.16% 12.46% 16.48% 8.37% 9.87% 10.93% 10.07%
Pre Tax Income Margin		 24.71% 24.55% 23.91% 19.16% 17.32% 16.23% 11.65% 14.06% 13.60% 12.56%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 98.98% 112.42% 104.19% 36.49% 61.83% 92.48% 292.91% 149.91% 123.93%

Quarterly Metrics And Ratios for Synopsys

This table displays calculated financial ratios and metrics derived from Synopsys' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.68% 11.81% 12.65% 15.20% 10.99% 63.67% 8.55% -1.29% 7.17% -28.98% 18.03%
EBITDA Growth		 -32.97% -6.06% 16.56% 13.49% 51.97% 77.28% 30.83% -7.59% -12.40% 3.03% 11.71%
EBIT Growth		 -36.36% -21.99% 20.41% 15.15% 63.83% 101.98% 37.74% -12.71% -14.67% 0.50% 10.79%
NOPAT Growth		 -23.19% -33.13% 26.74% 7.12% 36.04% 156.61% 40.98% -14.56% -25.90% -27.22% 15.77%
Net Income Growth		 -33.35% 216.20% 21.57% 7.09% 66.11% 128.62% 51.63% -8.15% -14.27% -24.65% 10.71%
EPS Growth		 -34.60% 218.30% 20.28% 6.82% 65.14% 128.57% 51.75% -6.88% -12.06% -22.83% 12.60%
Operating Cash Flow Growth		 23.16% 72.61% -18.61% -32.20% -176.50% -17.14% 27.25% -6.27% -26.32% 6.19% 4.25%
Free Cash Flow Firm Growth		 127.54% -281.35% -287.77% -2,437.24% -8,224.84% 917.75% 237.65% -109.71% -104.88% -131.54% -239.42%
Invested Capital Growth		 1.09% 27.49% 21.20% 15.69% 23.94% -2.53% 0.99% 7.24% 6.15% 5.14% 10.99%
Revenue Q/Q Growth		 -2.83% -1.84% 4.88% -11.79% 12.80% -1.10% 7.26% -7.24% 6.00% -34.41% -2.46%
EBITDA Q/Q Growth		 -21.63% -3.52% 11.91% -21.89% 9.84% 19.70% 8.97% 6.07% 22.79% -11.66% -23.03%
EBIT Q/Q Growth		 -7.65% -19.58% 14.78% -26.57% 13.20% 24.12% 9.77% 6.22% 31.63% -15.35% -30.44%
NOPAT Q/Q Growth		 7.15% -38.19% 34.92% -16.55% -6.71% 17.15% 14.03% 9.16% 58.54% -35.64% -30.89%
Net Income Q/Q Growth		 -72.85% 170.59% 40.06% -35.21% 28.78% 4.04% 23.38% 0.49% 77.24% -31.00% -25.26%
EPS Q/Q Growth		 -73.49% 173.18% 38.83% -34.95% 29.02% 3.23% 23.30% 0.57% 78.57% -31.47% -24.34%
Operating Cash Flow Q/Q Growth		 -111.99% 23.58% -4.44% 642.88% -126.92% -41.73% -20.40% 512.58% -70.84% -10.50% -41.37%
Free Cash Flow Firm Q/Q Growth		 123.66% -67.60% -34.41% 47.60% -255.81% 73.53% 1,916.17% -69.53% 78.94% 70.79% -228.12%
Invested Capital Q/Q Growth		 10.45% -1.62% 4.41% -10.89% 39.29% -6.47% -0.34% -4.54% 9.54% -3.09% 5.83%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 81.45% 78.30% 80.95% 79.35% 81.52% 82.25% 80.77% 80.34% 79.11% 85.70% 78.27%
EBITDA Margin		 24.87% 30.84% 31.38% 29.41% 35.74% 36.71% 30.33% 29.85% 26.10% 33.89% 25.16%
Operating Margin		 17.30% 20.28% 23.61% 22.83% 23.34% 31.72% 22.16% 23.15% 18.80% 24.93% 18.75%
EBIT Margin		 20.00% 21.05% 25.69% 23.48% 30.28% 30.17% 24.04% 23.49% 20.51% 24.44% 18.94%
Profit (Net Income) Margin		 20.44% 73.15% 26.54% 19.87% 29.53% 25.87% 24.59% 21.38% 19.73% 18.52% 17.60%
Tax Burden Percent		 102.16% 347.56% 103.29% 84.65% 97.54% 85.75% 102.30% 91.02% 96.20% 75.75% 92.93%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate		 -2.16% 20.97% -7.83% 13.30% 5.01% 15.49% -2.14% 8.07% 3.80% 31.43% 7.07%
Return on Invested Capital (ROIC)		 19.59% 22.07% 35.73% 27.64% 24.62% 35.96% 28.61% 27.06% 21.91% 20.15% 21.90%
ROIC Less NNEP Spread (ROIC-NNEP)		 18.00% -5.06% 35.00% 27.58% 15.85% 36.62% 27.01% 26.99% 20.14% 19.38% 21.75%
Return on Net Nonoperating Assets (RNNOA)		 -5.68% 2.10% -11.44% -8.46% -3.25% -11.90% -7.71% -7.92% -4.60% -5.40% -5.90%
Return on Equity (ROE)		 13.91% 24.17% 24.29% 19.18% 21.37% 24.06% 20.90% 19.13% 17.31% 14.75% 16.00%
Cash Return on Invested Capital (CROIC)		 20.61% 4.29% 10.88% 14.34% 4.52% 32.47% 22.59% 14.97% 15.97% 20.62% 16.46%
Operating Return on Assets (OROA)		 10.29% 11.02% 15.47% 14.27% 16.45% 16.24% 13.14% 12.75% 11.49% 12.42% 10.53%
Return on Assets (ROA)		 10.52% 38.30% 15.98% 12.08% 16.05% 13.93% 13.44% 11.60% 11.05% 9.41% 9.78%
Return on Common Equity (ROCE)		 13.88% 24.06% 24.16% 19.06% 21.24% 23.90% 20.74% 18.99% 17.24% 14.68% 15.92%
Return on Equity Simple (ROE_SIMPLE)		 22.43% 0.00% 19.28% 19.78% 20.92% 0.00% 17.17% 15.60% 16.56% 0.00% 18.34%
Net Operating Profit after Tax (NOPAT)		 257 240 388 288 335 359 306 269 246 140 217
NOPAT Margin		 17.68% 16.03% 25.46% 19.79% 22.17% 26.80% 22.63% 21.28% 18.09% 17.10% 17.42%
Net Nonoperating Expense Percent (NNEP)		 1.59% 27.13% 0.73% 0.06% 8.77% -0.66% 1.60% 0.07% 1.77% 0.77% 0.15%
Return On Investment Capital (ROIC_SIMPLE)		 2.76% 2.67% - - 5.01% 5.82% - - - 2.53% -
Cost of Revenue to Revenue		 18.55% 21.70% 19.05% 20.65% 18.48% 17.75% 19.23% 19.66% 20.89% 14.30% 21.73%
SG&A Expenses to Revenue		 11.48% 11.01% 9.86% 7.89% 8.69% 7.08% 7.36% 6.71% 7.15% 8.20% 7.33%
R&D to Revenue		 38.01% 35.27% 33.35% 33.90% 34.78% 32.82% 35.77% 36.47% 34.18% 45.34% 35.65%
Operating Expenses to Revenue		 64.14% 58.01% 57.34% 56.52% 58.19% 50.53% 58.62% 57.19% 60.31% 60.77% 59.52%
Earnings before Interest and Taxes (EBIT)		 291 315 392 342 457 404 326 297 279 200 236
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 362 462 479 428 540 492 411 377 355 277 314
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 8.73 8.78 11.10 11.32 12.16 11.61 11.54 9.70 9.57 8.11 10.03
Price to Tangible Book Value (P/TBV)		 14.27 14.76 21.39 23.47 37.52 27.87 39.65 35.65 38.22 34.76 41.81
Price to Revenue (P/Rev)		 13.38 12.88 13.17 12.80 14.84 13.43 13.06 10.97 10.42 9.69 11.36
Price to Earnings (P/E)		 38.50 34.86 57.09 56.73 57.63 58.05 66.47 61.43 57.21 45.43 54.44
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 2.60% 2.87% 1.75% 1.76% 1.74% 1.72% 1.50% 1.63% 1.75% 2.20% 1.84%
Enterprise Value to Invested Capital (EV/IC)		 14.05 15.01 16.49 16.34 14.66 17.85 16.01 13.08 11.98 10.77 13.22
Enterprise Value to Revenue (EV/Rev)		 12.75 12.22 12.87 12.55 14.61 13.14 12.73 10.65 10.18 9.37 11.06
Enterprise Value to EBITDA (EV/EBITDA)		 44.55 39.09 43.04 42.33 43.91 42.74 46.75 41.12 38.55 30.77 39.20
Enterprise Value to EBIT (EV/EBIT)		 57.46 49.47 52.28 51.76 53.85 53.52 60.14 53.62 49.35 39.18 49.67
Enterprise Value to NOPAT (EV/NOPAT)		 65.11 59.14 60.14 60.65 62.65 58.94 68.24 61.67 56.24 43.08 51.74
Enterprise Value to Operating Cash Flow (EV/OCF)		 54.25 53.23 71.44 62.25 53.24 41.02 37.82 33.27 31.03 24.86 31.91
Enterprise Value to Free Cash Flow (EV/FCFF)		 68.55 392.40 166.11 122.18 358.98 54.29 71.22 90.46 77.25 53.55 84.49
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.32 -0.41 -0.33 -0.31 -0.20 -0.33 -0.29 -0.29 -0.23 -0.28 -0.27
Leverage Ratio		 1.47 1.54 1.57 1.59 1.62 1.68 1.65 1.65 1.67 1.67 1.65
Compound Leverage Factor		 1.47 1.54 1.57 1.59 1.62 1.68 1.65 1.65 1.67 1.67 1.65
Debt to Total Capital		 0.15% 0.17% 0.20% 0.24% 0.25% 0.29% 0.30% 0.34% 0.36% 0.37% 0.39%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.15% 0.17% 0.20% 0.24% 0.25% 0.29% 0.30% 0.34% 0.36% 0.37% 0.39%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.36% 0.46% 0.50% 0.53% 0.60% 0.69% 0.70% 0.74% 0.78% 0.84%
Common Equity to Total Capital		 99.85% 99.47% 99.33% 99.27% 99.22% 99.11% 99.01% 98.96% 98.90% 98.85% 98.77%
Debt to EBITDA		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.02
Net Debt to EBITDA		 -2.18 -2.11 -1.02 -0.88 -0.69 -0.96 -1.27 -1.25 -0.94 -1.10 -1.08
Long-Term Debt to EBITDA		 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.02
Debt to NOPAT		 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02
Net Debt to NOPAT		 -3.19 -3.19 -1.42 -1.26 -0.99 -1.32 -1.85 -1.88 -1.37 -1.54 -1.43
Long-Term Debt to NOPAT		 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02
Altman Z-Score		 14.94 13.55 15.03 14.56 14.34 11.93 12.12 10.21 9.85 8.37 10.64
Noncontrolling Interest Sharing Ratio		 0.22% 0.46% 0.56% 0.59% 0.63% 0.69% 0.76% 0.76% 0.41% 0.44% 0.48%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.68 2.44 2.02 1.86 1.29 1.15 1.20 1.15 1.11 1.09 1.14
Quick Ratio		 1.99 1.88 1.10 0.99 0.88 0.82 0.92 0.90 0.86 0.85 0.87
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 198 -835 -498 -371 -718 461 265 -15 -8.62 -56 -193
Operating Cash Flow to CapEx		 -165.68% 12,823.38% 1,138.27% 1,242.03% -217.35% 614.07% 1,213.48% 1,449.63% 260.06% 1,088.59% 1,236.24%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.51 0.52 0.60 0.61 0.54 0.54 0.55 0.54 0.56 0.51 0.56
Accounts Receivable Turnover		 6.21 6.84 8.82 7.83 5.21 6.44 7.80 6.86 4.99 6.77 7.85
Inventory Turnover		 3.10 3.62 4.04 4.16 3.40 3.84 4.28 4.62 5.03 4.07 4.41
Fixed Asset Turnover		 10.91 11.01 11.73 11.36 10.09 10.29 10.29 9.93 10.40 9.66 10.34
Accounts Payable Turnover		 1.51 1.12 1.62 1.97 1.51 1.10 1.31 1.65 1.81 1.16 1.50
Days Sales Outstanding (DSO)		 58.82 53.35 41.36 46.61 70.08 56.72 46.79 53.19 73.18 53.95 46.48
Days Inventory Outstanding (DIO)		 117.81 100.75 90.45 87.75 107.40 95.16 85.25 78.94 72.56 89.61 82.80
Days Payable Outstanding (DPO)		 241.87 325.86 224.84 185.07 242.53 330.94 278.49 220.72 201.44 315.12 242.90
Cash Conversion Cycle (CCC)		 -65.24 -171.77 -93.02 -50.70 -65.06 -179.06 -146.45 -88.59 -55.71 -171.55 -113.62
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 5,510 4,988 5,070 4,856 5,450 3,913 4,183 4,198 4,397 4,014 4,142
Invested Capital Turnover		 1.11 1.38 1.40 1.40 1.11 1.34 1.26 1.27 1.21 1.18 1.26
Increase / (Decrease) in Invested Capital		 60 1,076 887 659 1,053 -102 41 283 255 196 410
Enterprise Value (EV)		 77,433 74,895 83,601 79,331 79,893 69,864 66,971 54,918 52,678 43,233 54,755
Market Capitalization		 81,228 78,898 85,544 80,938 81,114 71,394 68,746 56,553 53,918 44,734 56,217
Book Value per Share		 $60.19 $58.53 $50.32 $46.89 $43.80 $40.42 $39.16 $38.29 $36.98 $36.07 $36.63
Tangible Book Value per Share		 $36.81 $34.81 $26.10 $22.61 $14.20 $16.84 $11.40 $10.42 $9.26 $8.42 $8.79
Total Capital		 9,319 9,039 7,761 7,206 6,724 6,202 6,018 5,893 5,699 5,580 5,674
Total Debt		 14 16 16 17 17 18 18 20 21 21 22
Total Long-Term Debt		 14 16 16 17 17 18 18 20 21 21 22
Net Debt		 -3,795 -4,035 -1,979 -1,643 -1,256 -1,568 -1,816 -1,675 -1,281 -1,545 -1,509
Capital Expenditures (CapEx)		 41 4.39 40 38 40 53 46 48 44 36 36
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 156 -231 599 485 -510 -1,140 -1,296 -1,283 -999 -1,327 -1,178
Debt-free Net Working Capital (DFNWC)		 3,965 3,820 2,593 2,145 763 445 538 412 303 238 353
Net Working Capital (NWC)		 3,965 3,820 2,593 2,145 763 445 538 412 303 238 353
Net Nonoperating Expense (NNE)		 -40 -856 -16 -1.20 -111 13 -27 -1.18 -22 -12 -2.25
Net Nonoperating Obligations (NNO)		 -3,795 -4,035 -2,675 -2,332 -1,256 -2,271 -1,816 -1,675 -1,281 -1,545 -1,509
Total Depreciation and Amortization (D&A)		 71 147 87 86 83 88 85 80 76 77 78
Debt-free, Cash-free Net Working Capital to Revenue		 2.56% -3.77% 9.22% 7.67% -9.33% -21.44% -24.63% -24.89% -19.30% -28.76% -23.80%
Debt-free Net Working Capital to Revenue		 65.30% 62.34% 39.93% 33.92% 13.96% 8.37% 10.23% 8.00% 5.87% 5.16% 7.14%
Net Working Capital to Revenue		 65.30% 62.34% 39.93% 33.92% 13.96% 8.37% 10.23% 8.00% 5.87% 5.16% 7.14%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $1.91 $7.26 $2.66 $1.91 $2.95 $2.30 $2.21 $1.79 $1.78 $1.00 $1.46
Adjusted Weighted Average Basic Shares Outstanding		 154.41M 153.14M 153.42M 152.97M 152.31M 152.15M 152.02M 152.19M 152.40M 153.00M 152.94M
Adjusted Diluted Earnings per Share		 $1.89 $7.13 $2.61 $1.88 $2.89 $2.24 $2.17 $1.76 $1.75 $0.98 $1.43
Adjusted Weighted Average Diluted Shares Outstanding		 156.19M 155.94M 156.13M 155.77M 155.33M 155.20M 154.95M 154.73M 155.08M 156.49M 155.81M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 154.62M 154.58M 153.61M 153.22M 152.54M 151.99M 304.17M 304.32M 152.30M 152.42M 152.91M
Normalized Net Operating Profit after Tax (NOPAT)		 176 240 252 288 335 356 225 264 286 139 217
Normalized NOPAT Margin		 12.11% 16.03% 16.53% 19.79% 22.17% 26.55% 16.64% 20.88% 20.97% 17.03% 17.42%
Pre Tax Income Margin		 20.00% 21.05% 25.69% 23.48% 30.28% 30.17% 24.04% 23.49% 20.51% 24.44% 18.94%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 20.18% 42.41% 0.00% 98.98% 122.02% 132.53% 123.78% 112.42% 94.58%

Frequently Asked Questions About Synopsys' Financials

When does Synopsys's financial year end?

According to the most recent income statement we have on file, Synopsys' fiscal year ends in October. Their fiscal year 2024 ended on October 31, 2024.

How has Synopsys' net income changed over the last 9 years?

Synopsys' net income appears to be on an upward trend, with a most recent value of $2.24 billion in 2024, rising from $225.93 million in 2015. The previous period was $1.22 billion in 2023. Check out Synopsys' forecast to explore projected trends and price targets.

What is Synopsys's operating income?
Synopsys's total operating income in 2024 was $1.36 billion, based on the following breakdown:
  • Total Gross Profit: $4.88 billion
  • Total Operating Expenses: $3.53 billion
How has Synopsys revenue changed over the last 9 years?

Over the last 9 years, Synopsys' total revenue changed from $2.24 billion in 2015 to $6.13 billion in 2024, a change of 173.3%.

How much debt does Synopsys have?

Synopsys' total liabilities were at $4.05 billion at the end of 2024, a 2.4% decrease from 2023, and a 111.9% increase since 2015.

How much cash does Synopsys have?

In the past 9 years, Synopsys' cash and equivalents has ranged from $723.12 million in 2018 to $3.90 billion in 2024, and is currently $3.90 billion as of their latest financial filing in 2024.

How has Synopsys' book value per share changed over the last 9 years?

Over the last 9 years, Synopsys' book value per share changed from 20.10 in 2015 to 58.53 in 2024, a change of 191.2%.


Related Companies

This page (NASDAQ:SNPS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
3..2..1.. AI 2.0 ignition (don’t sleep on this)
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored